The Relationship among Health Beliefs, Depressive Symptoms, Medication Adherence, and Social Support in African Americans with Hypertension

Journal of Cardiovascular Nursing

Volumn 34, Issue 1, 2019, Pages 44-51

  Spikes, Telisa ^a   Higgins, Melinda ^a   Quyyumi, Arshed ^b   Reilly, Carolyn ^c   Pemu, Pricilla ^a   Dunbar, Sandra ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; hypertension; hypertension beliefs; medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; SELF CONCEPT; SOCIAL SUPPORT;

ADULT; AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SELF EFFICACY; SOCIAL SUPPORT;

EID: 85058694199     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0000000000000519     Document Type: Article

References (61)

1. Yoon S Fryar C Carroll M. Hypertension prevalence and control among adults: United States, 2011-2014. NCHS data brief, no. 220. In: National Center for Health Statistics, ed. Vol 220. Hyattsville, MD: U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics; 2015.
2. Dave GJ Bibeau DL Schulz MR. Predictors of uncontrolled hypertension in the stroke belt. J Clin Hypertens (Greenwich). 2013; 15 (8): 562-569.
3. Benjamin EJ Virani SS Callaway CW. Heart disease and stroke statistics-2018 update: A report from the American Heart Association. Circulation. 2018; 137 (6): e67-e492.
4. Whelton P Carey R Aronow W. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2017; 71 (6): 1269-1324.
5. Solomon A Schoenthaler A Seixas A Ogedegbe G Jean-Louis G Lai D. Medication routines and adherence among hypertensive African Americans. J Clin Hypertens (Greenwich). 2015; 17 (9): 668-672.
6. More than half of all African-Americans have high blood pressure under new diagnostic guidelines [press release]. Anaheim, California: American Heart Association,. November 14th, 2017.
7. Buckley L Labonville S Barr J. A systematic review of beliefs about hypertension and its treatment among African Americans. Curr Hypertens Rep. 2016; 18 (7): 52-61.
8. Lewis LM Ogedegbe C Ogedegbe G. Enhancing adherence of antihypertensive regimens in hypertensive African-Americans: current and future prospects. Expert Rev Cardiovasc Ther. 2012; 10 (11): 1375-1380.
9. Kressin NR Wang F Long J. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med. 2007; 22 (6): 768-774.
10. Peters RM Aroian KJ Flack JM. African American culture and hypertension prevention. West J Nurs Res. 2006; 28 (7): 831-863.
11. Whelton PK Einhorn PT Muntner P. Research needs to improve hypertension treatment and control in African Americans. Hypertension. 2016; 68 (5): 1066-1072.
12. Krousel-Wood M Islam T Muntner P. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010; 40 (3): 248-257.
13. Abel WM Crane PB McCoy T. Predictors of depression in black women with hypertension. Issues Ment Health Nurs. 2014; 35 (3): 165-174.
14. Morris AB Li J Kroenke K Bruner-England TE Young JM Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006; 26 (4): 483-492.
15. Flynn SJ Ameling JM Hill-Briggs F. Facilitators and barriers to hypertension self-management in urban African Americans: perspectives of patients and family members. Patient Prefer Adherence. 2013; 7: 741-749.
16. Hill MN Bone LR Kim MT Miller DJ Dennison CR Levine DM. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 1999; 12 (10 pt 1): 951-958.
17. Cené CW Dennison CR Powell Hammond W Levine D Bone LR Hill MN. Antihypertensive medication nonadherence in black men: direct and mediating effects of depressive symptoms, psychosocial stressors, and substance use. J Clin Hypertens (Greenwich). 2013; 15 (3): 201-209.
18. Braverman J Dedier J. Predictors of medication adherence for African American patients diagnosed with hypertension. Ethn Dis. 2009; 19 (4): 396-400.
19. Strom JL Egede LE. The impact of social support on outcomes in adult patients with type 2 diabetes: A systematic review. Curr Diab Rep. 2012; 12 (6): 769-781.
20. Aguilar M Bhuket T Torres S Liu B Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015; 313 (19): 1973-1974.
21. Falkner B Cossrow N. Prevalence of metabolic syndrome and obesity-Associated hypertension in the racial ethnic minorities of the United States. Curr Hypertens Rep. 2014; 16 (7): 449-463.
22. Colantonio LD Anstey DE Carson AP. Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study. J Clin Hypertens (Greenwich). 2017; 19 (6): 592-600.
23. Flack JM Sica DA Bakris G. Management of high blood pressure in Blacks: An update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010; 56 (5): 780-800.
24. Greer DB Ostwald SK. Improving adherence in African American women with uncontrolled hypertension. J Cardiovasc Nurs. 2015; 30 (4): 311-318.
25. Kirkendoll K Clark PC Grossniklaus D Igho-Pemu P Mullis R Dunbar SB. Metabolic syndrome in African Americans: views on making lifestyle changes. J Transcult Nurs. 2010; 21 (2): 104-113.
26. Holt-Lunstad J Uchino B Rimer BK. Social Support and Health. In: Glanz K Rimer BK Viswanath K, eds. Health Behavior and Health Education Theory, Research, and Practice. San Francisco, CA: Jossey-Bass; 2015: 183-204.
27. Glanz K Lewis M Rimer BK. The health belief model. In: National Institutes of Health, ed. Theory at a Glance: A Guide for Health Promotion Practice. Jones & Bartlett Learning; 2002: 32-43.
28. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens (Greenwich). 2008; 10 (8): 644-645.
29. Munger MA Van Tassell BW Lafleur J. Medication nonadherence: An unrecognized cardiovascular risk factor. MedGenMed. 2007; 9 (3): 58.
30. Sherbourne CD Hays RD Ordway L DiMatteo MR Kravitz RL. Antecedents of adherence to medical recommendations: results from the medical outcomes study. J Behav Med. 1992; 15 (5): 447-468.
31. Kountz DS Kofman E. Improving medication routines and adherence in hypertensive African Americans: finding the needle in the haystack. J Clin Hypertens (Greenwich). 2015; 17 (9): 673-674.
32. Klootwyk JM Sanoski CA. Medication adherence and persistence in hypertension management. J Clin Outcomes Manag. 2011; 18 (8): 351Y358.
33. Iuga AO McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014; 7: 35-44.
34. Gwadry-Sridhar FH Manias E Lal L. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: A systematic review by the ISPOR Medication Adherence and Persistence Special Interest Group. Value Health. 2013; 16 (5): 863-871.
35. Parker CP Cunningham CL Carter BL Vander Weg MW Richardson KK Rosenthal GE. A mixed-method approach to evaluate a pharmacist intervention for veterans with hypertension. J Clin Hypertens (Greenwich). 2014; 16 (2): 133-140.
36. Svarstad BL Kotchen JM Shireman TI. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial. J Am Pharm Assoc (2003). 2013; 53 (5): 520-529.
37. American Heart Association. Cardiovascular Disease: A Costly Burden for America-Projections Through 2035. Washington, DC: The American Heart Association Office of Federal Advocacy; 2017.
38. Holmes EA Hughes DA Morrison VL. Predicting adherence to medications using health psychology theories: A systematic review of 20 years of empirical research. Value Health. 2014; 17 (8): 863-876.
39. Kronish IM Leventhal H Horowitz CR. Understanding minority patients' beliefs about hypertension to reduce gaps in communication between patients and clinicians. J Clin Hypertens (Greenwich). 2012; 14 (1): 38-44.
40. Lewis LM Askie P Randleman S Shelton-Dunston B. Medication adherence beliefs of community-dwelling hypertensive African Americans. J Cardiovasc Nurs. 2010; 25 (3): 199-206.
41. Bosworth HB Oddone EZ. A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc. 2002; 94 (4): 236-248.
42. Warren-Findlow J Issel LM. Stress and coping in African American women with chronic heart disease: A cultural cognitive coping model. J Transcult Nurs. 2010; 21 (1): 45-54.
43. Taylor J Washington O Artinian N Lichtenberg P. Parental stress among African American parents and grandparents. Issues Ment Health Nurs. 2007; 28 (4): 373-387.
44. James SA. John henryism and the health of African-Americans. Cult Med Psychiatry. 1994; 18 (2): 163-182.
45. Kim MT Han HR Hill MN Rose L Roary M. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med. 2003; 26 (1): 24-31.
46. Greer DB Abel WM. Religious/spiritual coping in older African American women. Qualitat Rep. 2017; 22 (1): 237-260.
47. McDonald MV Pezzin LE Peng TR Feldman PH. Understanding the complexity of hypertensive African American home care patients: challenges to intervention. Ethn Dis. 2009; 19 (2): 148-153.
48. Kim MT Hill MN Bone LR. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000; 15 (3): 90-96.
49. Coverson D Strickland OL. Conceptualization and Development of the Weight Perception and Control Scale. Atlanta, GA: Laney Graduate School Emory University Nell Hodgson Woodruff School of Nursing; 2003.
50. Culig J Leppee M. From Morisky to Hill-Bone; Self-Reports Scales for Measuring Adherence to Medication. Coll Antropol. 2014; 38 (1): 53-62.
51. Bucholz EM Strait KM Dreyer RP. Effect of low perceived social support on health outcomes in young patients with acute myocardial infarction: results from the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients) study. J Am Heart Assoc. 2014; 3 (5): e001252.
52. Beck AT Ward CH Mendelson M Mock J Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561-571.
53. Beck AT Steer R Brown G. Beck Depression Inventory. Philadelphia, PA, University of Pennsylvania; 2015.
54. Mishra S Gioia D Childress S Barnet B Webster R. Adherence to medication regimens among low-income patients with multiple comorbid chronic conditions. Health Soc Work. 2011; 36 (4): 249-258.
55. Kripalani S Goggins K Nwosu S. Medication nonadherence before hospitalization for acute cardiac events. J Health Commun. 2015; 20 (suppl 2): 34-42.
56. Ho M Bryson C Rumsfeld J. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119: 3028-3035.
57. Fongwa MN Evangelista LS Hays RD. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag. 2008; 4 (1): 157-166.
58. Warren-Findlow J Seymour RB. Prevalence rates of hypertension self-care activities among African Americans. J Natl Med Assoc. 2011; 103 (6): 503-512.
59. Grant AB Seixas A Frederickson K. Effect of expectation of care on adherence to antihypertensive medications among hypertensive blacks: Analysis of the Counseling African Americans to Control Hypertension (CAATCH) Trial. J Clin Hypertens (Greenwich). 2016; 18 (7): 690-696.
60. Fongwa MN Nandy K Yang Q Hays RD. The facilitators of and barriers to adherence to hypertension treatment scale. J Cardiovasc Nurs. 2015; 30 (6): 484-490.
61. Krousel-Wood M Joyce C Holt E. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension. 2011; 58: 804-810.